Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Yasgar

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|September 9, 2021
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2Wan-Chen Tsai, Nathan C Gilbert, Amanda Ohler, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
Plos One|August 30, 2016
A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell ModelsNatalia J Martinez, Ganesha Rai, Adam Yasgar, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 23, 2026
A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe DiscoveryAdam Yasgar, Sankalp Jain, Huanchen Wang, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Cell Reports|April 28, 2021
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteomeMark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, et al.
Chemical Research in Toxicology|November 3, 2020
The Tox21 10K Compound Library: Collaborative Chemistry Advancing ToxicologyAnn M Richard, Ruili Huang, Suramya Waidyanatha, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Journal of Medicinal Chemistry|April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of CancerJason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2023
Discovering selective antiferroptotic inhibitors of the 15LOX/PEBP1 complex noninterfering with biosynthesis of lipid mediatorsHaider H Dar, Karolina Mikulska-Ruminska, Yulia Y Tyurina, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|September 9, 2021
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2Wan-Chen Tsai, Nathan C Gilbert, Amanda Ohler, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
Plos One|August 30, 2016
A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell ModelsNatalia J Martinez, Ganesha Rai, Adam Yasgar, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 23, 2026
A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe DiscoveryAdam Yasgar, Sankalp Jain, Huanchen Wang, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Cell Reports|April 28, 2021
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteomeMark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, et al.
Chemical Research in Toxicology|November 3, 2020
The Tox21 10K Compound Library: Collaborative Chemistry Advancing ToxicologyAnn M Richard, Ruili Huang, Suramya Waidyanatha, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Journal of Medicinal Chemistry|April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of CancerJason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2023
Discovering selective antiferroptotic inhibitors of the 15LOX/PEBP1 complex noninterfering with biosynthesis of lipid mediatorsHaider H Dar, Karolina Mikulska-Ruminska, Yulia Y Tyurina, et al.
Pageof 7